GB:CLBX Stock Latest News
Company AnnouncementsCelLBxHealth inks Swiss biotech deal in fast-growing radiopharmaceuticals3w ago
Company AnnouncementsCelLBxHealth cuts losses, secures pharma deals and targets revenue surge in 20273w ago
Company AnnouncementsCelLBxHealth Secures New U.S. Pharma Contract for Parsortix CTC Analysis1M ago
Company AnnouncementsCelLBxHealth Highlights Parsortix Breakthrough in Glioblastoma Liquid Biopsy3M ago
Company AnnouncementsCelLBxHealth’s Parsortix platform bolsters ADC monitoring credentials in peer‑reviewed CTC study3M ago
Company AnnouncementsCelLBxHealth Ties Staff Rewards to Share Price With Large Option Grant4M ago
Company AnnouncementsCelLBxHealth Targets 50% Revenue Growth as CEO Search Begins4M ago
Company AnnouncementsCelLBxHealth CEO departs as board backs CTC growth strategy4M ago
Company AnnouncementsCelLBxHealth slashes costs and pivots to partnerships after revenue slide4M ago
Company AnnouncementsCelLBxHealth sets date for 2025 results and investor webcast5M ago
Company AnnouncementsCelLBxHealth strikes AstraZeneca services deal for CTC-powered analytics5M agoCompany AnnouncementsCelLBxHealth teams with AdventHealth to trial CTC-based cancer monitoring in community care6M ago
Company AnnouncementsCelLBxHealth partners with Royal Marsden on CTC-DNA study in advanced lung cancer7M ago
Company AnnouncementsCelLBxHealth strengthens board with new CEO and non-executive directors7M ago
Company AnnouncementsCelLBxHealth Drops FDA Device Listing to Refocus Spending on Growth9M ago
Company AnnouncementsCelLBxHealth Tightens Costs and Reshapes Strategy as 2025 Revenues Miss Target10M ago
Company AnnouncementsCelLBxHealth refreshes board and appoints new CEO to drive CTC growth strategy10M agoCompany AnnouncementsCelLBxHealth Executives and ESOT Boost Holdings After Oversubscribed Placing11M ago
